91 - Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization

Co-Author(s)

• ES

  Eric A. F. Simões, MD, M.B., B.S., DCH

  Children's Hospital Colorado
  Denver, Colorado, United States

  Disclosure: Disclosure(s): Abbvie: DSMB (); Astra Zeneca: Grant/Research Support (); Bill and Melinda Gates Foundation: DSMB (), Grant/Research Support (); GSK Inc.: DSMB (); Johnson and Johnson: Grant/Research Support (); Merck Inc: Advisor/Consultant (), Grant/Research Support (); Nivavax: Grant/Research Support (); Pfizer Inc: Advisor/Consultant (), Grant/Research Support (); Regeneron: Grant/Research Support (); Sanofi Pasteur: Advisor/Consultant ()
• SM

  Shabir A. Madhi, MBBCh, FCPaeds, MMed, PhD

  South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit and African Leadership in Vaccinology Expertise, Faculty of Health Sciences, University of the Witwatersrand
  Parktown, Gauteng, South Africa

  Disclosure: Disclosure(s): AstraZeneca: Funding to institution for conduct of study ()

Presenting Author(s)

• 

  Kimberly J. Center, M.D.

  Senior Director
  Pfizer
  Collegeville, Pennsylvania, United States

  Disclosure: Disclosure(s): Pfizer: Employee (), Stocks/Bonds ()

Co-Author(s)

• CL

  Conrado J. Llapur, MD

  Hospital del Niño Jesús
  San Miguel de Tucuman, Tucuman, Argentina

  Disclosure: Disclosure(s): No financial relationships to disclose
• JN

  Jose M. Novoa Pizarro, MD

  Chief of Neonatolology. Associate Professor of Pediatrics.
  Hospital Padre Hurtado
  Santiago, Region Metropolitana, Chile

  Disclosure: Disclosure(s): AstraZeneca: Grant/Research Support (); Medimmune: Grant/Research Support (); MSD: Grant/Research Support (); Pfizer: Grant/Research Support (); Regeneron: Grant/Research Support ()
• KS

  Kena A. Swanson, Ph.D.

  Vice President, Viral Vaccines
  Pfizer
  Pearl River, New York, United States

  Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()
• DR

  David Radley, MS

  Senior Director, Biostatistics
  Pfizer
  Pearl River, New York, United States

  Disclosure: Disclosure(s): Pfizer: Employee (), Stocks/Bonds ()
• SM

  Stephanie B. McGrory, B.S.N.

  Pfizer
  Collegeville, Pennsylvania, United States

  Disclosure: Disclosure(s): Pfizer: Employee (), Stocks/Bonds ()
• EG

  Emily A. Gomme, Ph.D.

  Director, High-throughput Clinical Immunoassays & Diagnostics
  Pfizer
  Westwood, New Jersey, United States

  Disclosure: Disclosure(s): Pfizer: Stocks/Bonds ()
• DS

  Daniel A. Scott, MD

  Vice President
  Pfizer
  Collegeville, Pennsylvania, United States

  Disclosure: Disclosure(s): Pfizer: Employee (), Stocks/Bonds ()
• KJ

  Kathrin U. Jansen, PhD

  SVP and Head Vaccine R&D
  Pfizer
  New York, New York, United States

  Disclosure: Disclosure(s): Pfizer Inc: Employee (), Stocks/Bonds ()
• 

  William C. Gruber, MD

  SVP
  Pfizer
  Pearl River, New York, United States

  Disclosure: Disclosure(s): Pfizer Inc: Employee (), Stocks/Bonds ()
• AG

  Alejandra C. Gurtman, M.D.

  Vice President
  Pfizer
  Pearl River, New York, United States

  Disclosure: Disclosure(s): Pfizer: employee of Pfizer ()